These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 13990395)
1. [Inhibition of antibody production in response to antigens of normal and tumor-bearing rabbit tissues in rats with developed tolerance]. RADZIKHOVSKAIA RM Vopr Onkol; 1962; 8(11)():8-10. PubMed ID: 13990395 [No Abstract] [Full Text] [Related]
2. [Immune response in non-inbred rats after implantation of Geren carcinoma into their spleens]. Fil'chakov FV; Grinevich IuA; Shumilina ES; Khranovskaia NN; Bobro LI Vopr Onkol; 2004; 50(1):75-80. PubMed ID: 15088526 [TBL] [Abstract][Full Text] [Related]
3. Self-tolerance does not restrict the CD4+ T-helper response against the p53 tumor antigen. Lauwen MM; Zwaveling S; de Quartel L; Ferreira Mota SC; Grashorn JA; Melief CJ; van der Burg SH; Offringa R Cancer Res; 2008 Feb; 68(3):893-900. PubMed ID: 18245492 [TBL] [Abstract][Full Text] [Related]
4. [Application of antigen and antibody counter-diffusion method in investigation of liver proteins during carcinogenesis]. KOROSTELEVA TA Vopr Onkol; 1959; 5(1):22-8. PubMed ID: 13648176 [No Abstract] [Full Text] [Related]
5. Alpha1,2fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl Lewis X antigen generated within colorectal tumor tissues. Tsuboi K; Asao T; Ide M; Hashimoto S; Noguchi K; Kominato Y; Saniabadi AR; Kuwano H; Yazawa S Ann Surg Oncol; 2007 Jun; 14(6):1880-9. PubMed ID: 17375356 [TBL] [Abstract][Full Text] [Related]
6. On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoires. Sarma S; Bai XF; Liu JQ; May KF; Zheng P; Liu Y Cancer Res; 2003 Sep; 63(18):6051-5. PubMed ID: 14522934 [TBL] [Abstract][Full Text] [Related]
7. Visualization of naturally occurring Foxp3+ regulatory T cells in normal and tumor-bearing mice. Hontsu S; Yoneyama H; Ueha S; Terashima Y; Kitabatake M; Nakano A; Ito T; Kimura H; Matsushima K Int Immunopharmacol; 2004 Dec; 4(14):1785-93. PubMed ID: 15531294 [TBL] [Abstract][Full Text] [Related]
8. Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulation. Muta M; Matsumoto G; Nakashima E; Toi M Clin Cancer Res; 2006 Jan; 12(1):264-72. PubMed ID: 16397051 [TBL] [Abstract][Full Text] [Related]
9. [Radioimmunotherapy with 131 I-labeled humanized anti-HBsAg Fab and anti-nucleus antigen monoclonal antibody chTNT in nude mice bearing human hepatocellular carcinoma]. DU YF; Luo RC; Li GP; Li AM; Ding XM; Yan X; Huang K Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):460-2. PubMed ID: 18359714 [TBL] [Abstract][Full Text] [Related]
10. [Effect of a dose of tumor tissue antigens on specific antibody formation]. FILATOV PP Biull Eksp Biol Med; 1959 Jun; 47(6):95-100. PubMed ID: 13671079 [No Abstract] [Full Text] [Related]
12. Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker. Reimer TA; Anagnostopoulos I; Erdmann B; Lehmann I; Stein H; Daniel P; Dörken B; Rehm A BMC Cancer; 2005 May; 5():47. PubMed ID: 15904507 [TBL] [Abstract][Full Text] [Related]
13. Antifertility effect of passive administration of antibodies to 80 kDa human sperm antigen and its synthetic peptides in male and female rats. Bandivdekar AH; Vernekar VJ; Kamada M; Raghavan VP Am J Reprod Immunol; 2005 Dec; 54(6):332-41. PubMed ID: 16305658 [TBL] [Abstract][Full Text] [Related]
14. A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats. Yamamoto Y; Ueda Y; Itoh T; Iwamoto A; Yamagishi H; Shimagaki M; Teramoto K Oncol Rep; 2006 Dec; 16(6):1277-84. PubMed ID: 17089050 [TBL] [Abstract][Full Text] [Related]
15. Elevated antibody response by antigen presentation in immune complexes. Barabas AZ; Cole CD; Kovacs ZB; Lafreniere R Med Sci Monit; 2007 May; 13(5):BR119-24. PubMed ID: 17476190 [TBL] [Abstract][Full Text] [Related]
16. Amentoflavone, a biflavonoid from Biophytum sensitivum augments lymphocyte proliferation, natural killer cell and antibody dependent cellular cytotoxicity through enhanced production of IL-2 and IFN-gamma and restrains serum sialic acid and gamma glutamyl transpeptidase production in tumor - bearing animals. Guruvayoorappan C; Kuttan G J Exp Ther Oncol; 2007; 6(4):285-95. PubMed ID: 18038762 [TBL] [Abstract][Full Text] [Related]
18. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. Mapara MY; Sykes M J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice. Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392 [TBL] [Abstract][Full Text] [Related]
20. The isolation of intermediary metabolites of L-lysine-U-C14 from tissues of tumor-bearing rats. DAVIS JR; MORRIS RN Cancer Res; 1963 Jan; 23():143-7. PubMed ID: 14025492 [No Abstract] [Full Text] [Related] [Next] [New Search]